Efficacy of metformin treatment in polycystic ovary syndrome
Učinkovitost zdravljenja sindroma policističnih jajčnikov z metforminom
DOI:
https://doi.org/10.18690/actabiomed.87Keywords:
polycystic ovary syndrome, metformin, pharmacogenetics, personalized medicineAbstract
Metformin is an oral antidiabetic drug with potentially beneficial effects in patients with polycystic ovary syndrome (PCOS). Different pharmacological responses to met- formin have been reported in PCOS patients, which may be attributable to various clinical, biochemical, genetic and other factors. Here, we have outlined a short review of the results from current clinical studies on metformin efficacy in PCOS patients. Additionally, preliminary results from a retrospective pharmacogenetic study by our group on a sample of Slovene PCOS patients are presented. Pharmacogenetics is an emerging science that should pro- vide options for individualized medicine, the future of healthcare.
Downloads
Download data is not yet available.

Downloads
Published
27.11.2021
Issue
Section
Articles
How to Cite
Jerenec, K., Samojlenko, M., Geršak, K., & Ferk, P. (2021). Efficacy of metformin treatment in polycystic ovary syndrome: Učinkovitost zdravljenja sindroma policističnih jajčnikov z metforminom. Acta Medico-Biotechnica, 6(2), 13-20. https://doi.org/10.18690/actabiomed.87